Always consult a healthcare professional before beginning any peptide regimen, particularly for off-label or experimental uses
Peptide Vials (Retatrutide, 10 mg each): 12 weeks (Standard to 6 mg): 5 vials 24 weeks (Standard to 8 mg): 15 vials 12 weeks (Aggressive to 8 mg): 6 vials Insulin Syringes (U-100, 1 mL capacity): Per week: 12 syringes (depending on dose
The absence of serious adverse events, treatment-related withdrawals, IGF-1 elevation, glucose metabolism impairment, or immunogenic responses represents a favorable safety foundation
Clinical Benefits Directly promotes healing of gastric and duodenal ulcers, reduces inflammatory bowel symptoms, protects against digestive tract damage, and enhances overall mucosal integrity
Remember, serious side effects are very rare